Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > 0 04

<< Previous

Bullboard Posts

Next >>

Comment by Nighttradeon Sep 09, 2020 10:30am

133 Views

Post# 31526272

RE:RE:0 04

For a news driven stock .04 is horrible. Flippers can drive a stock at this price range 0.01 to 0.02 on any given week. They implied phase one could start and it moved 0.04. Blhahahahahha Investors beware.....

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing